Perfect Medical Industry Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	779.02	744.16	734.13	677.04	724.61
Revenue Growth (YoY)	4.68%	1.36%	8.43%	-6.57%	-10.29%
Cost of Revenue	578.25	505.96	533.58	542.63	515.08
Gross Profit	200.76	238.19	200.56	134.41	209.53
Selling, General & Admin	133.61	137.56	134.78	123.61	145.44
Research & Development	15.83	9.3	7.4	7.12	5.58
Operating Expenses	149.35	146.95	142.2	130.75	151.28
Operating Income	51.42	91.24	58.36	3.65	58.24
Interest Expense	-6.83	-3.72	-4.37	-4.46	-2.96
Interest & Investment Income	5.82	5.42	3.33	1.03	1.6
Currency Exchange Gain (Loss)	-	13.42	7.34	13.18	3.93
Other Non Operating Income (Expenses)	21.14	4.9	3.02	3.33	1.52
EBT Excluding Unusual Items	71.53	111.26	67.67	16.73	62.33
Gain (Loss) on Sale of Assets	-	0.4	1.19	1.18	0.19
Asset Writedown	-	-4.28	-14.61	-	-
Other Unusual Items	-	-	-	0.06	-
Pretax Income	71.53	107.38	54.25	17.98	62.52
Income Tax Expense	17.29	18.26	14.16	3.71	23.75
Net Income	54.25	89.12	40.09	14.27	38.77
Net Income to Common	54.25	89.12	40.09	14.27	38.77
Net Income Growth	-39.13%	122.31%	180.93%	-63.20%	-61.49%
Shares Outstanding (Basic)	54	49	46	44	41
Shares Outstanding (Diluted)	57	51	46	44	41
Shares Change (YoY)	11.61%	11.20%	3.98%	8.91%	-2.73%
EPS (Basic)	1.00	1.81	0.88	0.32	0.95
EPS (Diluted)	0.95	1.74	0.87	0.32	0.95
EPS Growth	-45.40%	100.00%	171.88%	-66.32%	-60.44%
Free Cash Flow	-88.46	45.84	85.17	52.87	-98.89
Free Cash Flow Per Share	-1.55	0.90	1.85	1.20	-2.43
Dividend Per Share	0.200	1.500	0.700	0.370	0.316
Dividend Growth	-86.67%	114.29%	89.19%	17.13%	-78.25%
Gross Margin	25.77%	32.01%	27.32%	19.85%	28.92%
Operating Margin	6.60%	12.26%	7.95%	0.54%	8.04%
Profit Margin	6.96%	11.98%	5.46%	2.11%	5.35%
Free Cash Flow Margin	-11.36%	6.16%	11.60%	7.81%	-13.65%
EBITDA	108.83	141.78	108	51.54	100.5
EBITDA Margin	13.97%	19.05%	14.71%	7.61%	13.87%
D&A For EBITDA	57.41	50.54	49.64	47.89	42.25
EBIT	51.42	91.24	58.36	3.65	58.24
EBIT Margin	6.60%	12.26%	7.95%	0.54%	8.04%
Effective Tax Rate	24.16%	17.00%	26.11%	20.62%	37.98%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.